Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey.
At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original purpose - from treating addiction to potentially impacting Alzheimer's. Ricks reveals how the company has revolutionized drug development by cutting traditional timelines in half, how it navigates global market challenges, and how it approaches drug pricing and innovation. A must-listen for anyone curious about the future of medicine!